NSE: GRANULES | BSE: 532482

Falling Comet

Download real time

464.40 13.10 (2.90%)

35.59% Fall from 52W High

561.4K NSE+BSE Volume

NSE 15 Apr, 2025 3:31 PM (IST)

11,263.7

Market Cap

High in industry

1.1

Beta 1Year

High Volatility

Granules India Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for GRANULES, BSE:532482 Granules India Ltd.

Search Inside the pdf :

Granules India Ltd.

17 Feb 2025

464.40

2.90%

GRANULES INDIA

Accumulate: Granules India Ltd.

Target

Geojit BNP Paribas

Granules India Ltd. is trading below all available SMAs

Granules India Ltd.

25 Jan 2025

464.40

2.90%

Finished dosages remain the key earnings driver

Buy: Granules India Ltd.

Target

Motilal Oswal

Granules India (GRAN) delivered better-than-expected revenue, while EBITDA/PAT stood in line for the quarter. The traction in finished dosage (FDF) remained robust for six quarters now.

Granules India Ltd. has an average target of 682.00 from 5 brokers.

Granules India Ltd.

08 Nov 2024

464.40

2.90%

New product launches and capacity expansion to drive growth

Buy: Granules India Ltd.

Target

KRChoksey

Granules revenue missed our estimate due to a significant decline in API and PFI sales. EBITDA missed our estimate due to higher-than-expected employee expenses.

Granules India Ltd. has an average target of 682.00 from 5 brokers.

Granules India Ltd.

06 Nov 2024

464.40

2.90%

Plants Resuming Operations and Upcoming Product Launches

Buy: Granules India Ltd.

Target

Sharekhan

Revenues stood at Rs. 957 crore, falling 19% y-o-y and 18% q-o-q, falling 5% short of our estimates.

Granules India Ltd. has lost -20.45% in the last 3 Months

Granules India Ltd.

12 Sep 2024

464.40

2.90%

Gagillapur site under a cloud

Buy: Granules India Ltd.

Motilal Oswal

Granules India (GRAN) was issued a Form 483 with six observations for its Gagillapur site after a recent USFDA inspection.

Granules India Ltd. has lost -23.72% in the last 6 Months

Granules India Ltd.

19 Aug 2024

464.40

2.90%

API decline to continue in FY25E

Buy: Granules India Ltd.

Recommendation Target

KRChoksey

GRANULES is expected to continue to see strong growth in FDFs with growth in new products; partially offset by continued weakness in APIs with higher channel inventory for Paracetamol APIs in regulated markets.
We expect the company to clock in 14.0% and 33.3% CAGR rise in revenue and net income, respectively, over FY24-FY26E (vs. 13.4% and 30.2% CAGR rise seen over FY24-FY26E earlier).

Granules India Ltd. is trading below all available SMAs

Granules India Ltd.

16 Aug 2024, 12:00AM

464.40

2.90%

GRANULES INDIA

Accumulate: Granules India Ltd.

Target

Geojit BNP Paribas

Granules India Ltd. has an average target of 682.00 from 5 brokers.

Granules India Ltd.

31 Jul 2024

464.40

2.90%

FD and low base doubled earnings YoY

Buy: Granules India Ltd.

Target

Motilal Oswal

Granules India (GRAN) posted in-line revenue in 1QFY25. However, it delivered better-than-estimated 1QFY25 EBITDA/PAT led by the increased share of formulation sales.